Living Cell Technologies Company
Living Cell Technologies develops insulin producing porcine pancreatic islets for the treatment of type 1 diabetes.
Technology:
Cell therapy, Stem cell therapy, diagnostics
Industry:
Geroscience, Public
Headquarters:
Manukau City, Auckland, New Zealand
Zip:
11-50
Founded Date:
1987-01-01
Employees Number:
11-50
Funding Status:
IPO
Investors Number:
6278203
Total Funding:
6278203
Estimated Revenue:
Less than $1M
Last Funding Date:
2011-01-18
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership